Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer (Q46966648)
scientific article published in March 2006
Language:
Current Data About Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer
(P31) (Q13442814)
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

(P50) (Q14947937)
(P1545) 3
(P1932) James L Abbruzzese
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

(P304) 1145-1151
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

(P407) (Q1860)

(P433) 7
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

(P478) 24
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

(P577) Wednesday, March 1, 2006
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

(P921) (Q5452194)

(Q180507)

(Q413299)
(P887)

(Q420207)
(P887)

(P1433) (Q400292)
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

(P1476) "Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer" (language: en)
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

(P2093) Christopher H Crane
(P1545) 1
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

Lee M Ellis
(P1545) 2
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

Christina Amos
(P1545) 4
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

Henry Q Xiong
(P1545) 5
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

Linus Ho
(P1545) 6
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

Douglas B Evans
(P1545) 7
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

Eric P Tamm
(P1545) 8
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

Chaan Ng
(P1545) 9
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

Peter W T Pisters
(P1545) 10
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

Chusilp Charnsangavej
(P1545) 11
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

Marc E Delclos
(P1545) 12
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

Michael O'Reilly
(P1545) 13
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

Jeffrey E Lee
(P1545) 14
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

Robert A Wolff
(P1545) 15
(P248)
(P698) 16505434
(P813) Tuesday, December 26, 2017
(P854) http://europepmc.org/abstract/MED/16505434

other details
description scientific article published in March 2006

External Links
(P356) 10.1200/JCO.2005.03.6780
(P698) 16505434